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Abstract We cloned and characterized the mouse uncoupling
protein 2 (UCP2) gene and its promoter region. The gene spans
approximately 6.3 kb and contains eight exons and seven introns.
Two short exons are located in the 5P untranslated region, and
each of the remaining exons encodes one of the transmembrane
domains. 3P-RACE analysis showed that a polyadenylation
signal 257 bp downstream from the stop codon was functional.
Primer extension analysis indicated a single transcriptional start
site 369 bp upstream from the translational start site. The
promoter region lacks both TATA and CAAT boxes but is GC-
rich. A construct containing 1250 bp of the promoter region
showed significant activity in all 6 cell lines examined, and the
region between 3160 and 3678 bp exhibited strong positive
regulatory activity. These features of the UCP2 gene are
different from those of the UCP1 gene and may contribute to
its ubiquitous expression.
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1. Introduction
Mitochondrial uncoupling protein 1 (previously UCP) is
exclusively expressed in the brown adipose tissue, which is a
thermogenic organ of mammals [1^4]. UCP1 uncouples mito-
chondrial respiration from ATP production by inducing the
exothermic movement of protons from outside to inside the
inner mitochondrial membrane and reducing their concentra-
tion gradients. Therefore, activation of UCP1 increases con-
sumption of calories and generation of heat [5]. These UCP1-
mediated e¡ects on energy expenditure are regulated mostly
by changes in the level of sympathetic nervous system activity
[6].
Recently, genes encoding novel members of the UCP family
(UCP2 and 3) have been cloned [7^10]. Although these pro-
teins show a high degree of homology to UCP1 (59 and 57%),
UCP3 mRNA is expressed predominantly in skeletal muscle
and UCP2 mRNA was detected in many tissues in humans
and rodents. The ubiquitous expression of the UCP2 gene
suggested that this molecule may be important for basal met-
abolic rate and regulation of body weight in mammals.
The partial genomic structure of the mouse and human
UCP2 have recently been reported [11,12]. However, the com-
plete structure including the transcriptional start site, number
of introns and functional polyadenylation signals etc. has not
been reported. In the present study, we established the com-
plete structure of the mouse UCP2 gene and characterized its
promoter region.
2. Materials and methods
2.1. Isolation of mouse uncoupling protein 2 genomic clones
A C57Bl/6UCBA mouse spleen genomic DNA library (Lambda
FIX II; Stratagene, USA) was used in this study. Approximately
1U106 recombinants were screened using a 32P-labeled mouse
UCP2 cDNA (1-UCP2). The 1-UCP2 cDNA was generated by pol-
ymerase chain reaction (PCR) using the primers U1, 5P-catcttctggga-
ggtagcaggaaat-3P, and U2, 5P-tttaccacatctgtaggctgggcta-3P, with mouse
skeletal muscle cDNA as a template. Filter hybridization was per-
formed using the previously described method [13,14]. Two genomic
clones were isolated and characterized by restriction endonuclease
mapping. The restriction digests were subjected to electrophoresis,
transferred onto a nylon membrane, and hybridized with the above
probe. All hybridized genomic fragments were subcloned into
pGEM4Z or 3Z (Promega, USA) for further restriction analysis and
sequenced using a Sequenase 2.0 (Amersham, USA) or SequiTherm
Long-Read Cycle sequencing kit (Epicenter Technologies, USA) and a
LI-COR model 4000 sequencer (LI-COR, USA).
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) and
5P rapid ampli¢cation of cDNA end
PCR was used to con¢rm the sizes of introns and exon-intron
boundaries. Aliquots of 3 Wg of total RNA from the skeletal muscle
were subjected to reverse transcription for 2 h at 37‡C. PCR ampli-
¢cation of cDNA was performed as previously described [14]. Several
primers were designed to span each exon/exon boundary (not shown).
Ampli¢cation products were gel puri¢ed, subcloned into the pGEMT-
Easy plasmid (Promega, USA) and sequenced.
To obtain the 5P portion of the mouse UCP2 cDNA, 5P-RACE
(rapid ampli¢cation of cDNA ends) was performed using a mouse
skeletal muscle Marathon Ready cDNA (Clontech, USA).
2.3. Primer extension analysis
Primer extension was carried out using the synthetic oligonucleotide
PE1, 5P-gagacgaaacacttaaagttcatac-3P, corresponding to a sequence
located in exon 2. The oligonucleotides were end-labeled with
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Fig. 1. Schematic representation of the mouse UCP2 gene. NcoI
(N), EcoRI (E), SalI, BglII and HindIII restriction sites are indi-
cated (SalI, BglII and HindIII are not unique sites, and SalI is lo-
cated in the multiple cloning site of the phage). Boxes denote exons,
while thin lines denote introns and £anking regions. ATG represents
the translational initiation site; STOP, stop codon; poly(A), poly-
adenylation signal.
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Fig. 2. Nucleotide sequence of the mouse UCP2 gene. Exons are shown in upper case letters. Introns and 5P and 3P untranslated region are in-
dicated in lower case letters. Proposed transcriptional initiation site is shown with an asterisk and is numbered +1. The ATTTA pentamer mo-
tif in the 3P untranslated region is underlined. The polyadenylation signal (ATAAA) is shown in bold type and the polyadenylation site is indi-
cated with an asterisk. Putative binding sites for Sp1, AP1, AP2, glucocorticoid response element (GRE) and CREB are underlined and
indicated.
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[Q-32P]ATP, hybridized to 5 Wg of poly(A) RNA extracted from the
mouse skeletal muscle and extended using AMV reverse transcriptase.
Forty micrograms of yeast tRNA were used as a negative control. The
primer-extended products were separated on an 8 M urea 6% poly-
acrylamide gel which was then dried and exposed to Kodak XAR-5
¢lm. The sizes of the resulting labeled primer-extended products were
inferred from their positions relative to Px174 RF DNA digested with
HaeIII and a sequencing ladder which was obtained using the same
primer (PE1) and a genomic clone containing the region upstream of
exon 2 as a template.
2.4. Analysis of 3P untranslated region by 3P rapid ampli¢cation
of cDNA ends (3P-RACE)
To detect functional polyadenylation signals in the 3P untranslated
region of the mouse UCP2 gene, 3P-RACE was performed as de-
scribed previously [15]. Brie£y, the ¢rst strand was synthesized with
5 Wg of total RNA from the mouse skeletal muscle and an
oligo(dT)17+ adapter primer (5P-gactcctgcagacatcgattttttttttttttttt-3P).
The ¢rst ampli¢cation was performed between the adapter
(5P-gactcctgcagacatcga-3P) (25 pmol of each primer) and a sequence-
speci¢c primer (RE1, 5P-tcaaacagttctacaccaagggctc-3P). The second
round of PCR was performed using 1 Wl of the ¢rst PCR product
with adapter and a downstream internal primer (RE2, 5P-ctgagctggt-
gacctatgacctcat-3P). The PCR products were analyzed electrophoreti-
cally using 1.5% agarose gels and subjected to Southern blot analysis.
Positive fragments were subcloned and sequenced.
2.5. Cell culture and transfection
L6, 3T3-L1, NIH-3T3, CV-1, GH4C1 and HeLa cells were cultured
in Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal bovine serum (FBS). Cells were plated 24 h before
transfection into 60-mm tissue culture dishes at subcon£uent density.
Transient transfection was performed by the calcium phosphate pre-
cipitation method with 3 Wg of reporter construct. The cells were then
harvested after a further 48 h.
2.6. Plasmid construction
The pGL3 basic vector (Promega, USA) is a promoterless luciferase
expression vector. The pGL3 control vector contains an SV40 pro-
moter and enhancer sequence linked to pGL3 basic and was used to
monitor transfection e⁄ciency in each cell line and as an internal
standard between di¡erent experiments. The mouse UCP2 gene
SalI-NcoI fragment containing 1250 bp of the promoter region, 110
bp of exon 1, approximately 760 bp of the ¢rst intron and 87 bp of
the second exon, was subcloned into the pGL3 basic vector and
named p1.2Luc. The p0.7Luc and p0.2Luc constructs containing
678 bp and 160 bp of the promoter region, respectively, were gener-
ated by deletion of the SalI-HindIII and Sal-BglII fragments from
p1.2Luc.
2.7. Luciferase assay
Assays for luciferase activity were performed using 10-Wl aliquots
from 400 Wl cell lysate and 350 Wl of 25 mM glycylglycine bu¡er (pH
7.8) containing 15 mM MgSO4, 4 mM EGTA, 16 mM KPO4, 1 mM
dithiothreitol and 2 mM ATP. The reaction was initiated by addition
of 200 Wl of 0.2 mM D-luciferin and light emission was measured for
10 s using a luminometer. Luc activity was expressed in arbitrary light
units (ALU) per microgram of cellular protein.
2.8. Statistical analysis
Statistical analysis was performed by ANOVA and Duncan’s multi-
ple range test.
3. Results
3.1. Genomic organization of the mouse UCP2 gene
Comparison of the genomic sequence with the cDNAs ob-
tained by RT-PCR and 5P-RACE established the organization
of the mouse UCP2 gene. The gene consists of eight exons
and seven introns that are £anked by typical splice donor and
acceptor sequences (Fig. 1). Two exons are interrupted by the
approximately 760-bp intron 1 in the 5P untranslated region of
the mouse UCP2 gene. With respect to the coding region,
followed by intron 2 with approximately 2.4 kb, exon 3
started 97 bp upstream of the ATG translation initiation co-
don. The remaining exons encoded each of the putative trans-
membrane domains, and exon 8 also encoded the entire 3P
untranslated region (Fig. 2).
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3.2. Characterization of the 3P untranslated region
Sequence analysis of the 3P-RACE product indicated a sin-
gle functional polyadenylation signal (ATAAA) 257 bp down-
stream of the stop codon in the mouse skeletal muscle, and
the thymidine residue 19 bp downstream of the signal was the
polyadenylation site (Fig. 3A). In addition, an ATTTA pen-
tamer motif was observed 99 bp downstream of the stop co-
don which may a¡ect mRNA stability (Fig. 2).
3.3. Promoter sequence
Primer extension with 5 Wg of poly(A) RNA from mouse
skeletal muscle and the PE1 primer gave a single strong signal
at 369 bp from the translational initiation site, while no sig-
ni¢cant signals were found in yeast transfer RNA (Fig. 3B).
Inspection of the sequence of the promoter region indicated
that there was no typical TATA box or CAAT box in close
proximity to the transcriptional start site. However, the pro-
moter region was GC-rich and several possible regulatory
elements were identi¢ed including complete sequence matches
for Sp1, AP-2, AP-1, CREB, and MyoD binding sites, and the
glucocorticoid response element (GRE) (Fig. 2).
3.4. Promoter function of the UCP2 gene in several cell lines
To determine whether the putative promoter region is func-
tional, a SalI-NcoI fragment containing 1250 bp of the pro-
moter region was subcloned into a luciferase reporter plasmid
(p1.2Luc) and transfected into 6 di¡erent cell lines. As shown
in Fig. 4A, signi¢cant expression was observed in all 6 cell
lines examined. In all cells, the promoterless reporter plasmid
(pGL3 basic) expressed luciferase at V0.3% of the level of
that driven by the SV40 promoter. Relative expression of
p1.2Luc to that of the SV40 promoter was high in L6 and
GH4C1 cells.
In L6 cells, deletion of the region between 31250 and 3678
bp from the transcriptional start site led to a slight increase,
but deletion from 3678 and 3160 bp resulted in a signi¢cant
decrease in promoter activity (Fig. 4B). These ¢ndings indi-
cated a strong positive regulatory activity such as an enhancer
in the region between 3678 and 3160 bp from the transcrip-
tional start site.
4. Discussion
In the present study we established the complete structure
of the mouse UCP2 gene which contains eight exons and
seven introns and spans a region of 6.3 kb. Although the
UCP1 gene contains no introns in the 5P untranslated region,
the mouse UCP2 gene contains two exons interrupted by the
approximately 740-bp intron 1 [15]. While the UCP1 gene
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Fig. 3. 3P-RACE and primer extension study of the mouse UCP2
gene. A: Representative sequence data from the 3P-RACE study. B:
Primer extension using the oligonucleotide PE1. The end-labeled pri-
mer was hybridized to 5 Wg of poly(A) RNA from the mouse skele-
tal muscle (muscle) or yeast tRNA (tRNA) and extended with
AMV reverse transcriptase. PE1 gave a positive signal at 369 bp
from the translational initiation site. Marker lanes C, T, A, and G
indicate sequencing ladder of the mouse UCP2 gene using the pri-
mer PE1. Px174 fragments digested with HaeIII and sizes of frag-
ments are indicated in bp on the left.
Fig. 4. Analysis of the mouse UCP2 gene promoter. A: 1250 bp of
the UCP2 gene promoter was subcloned in front of the luciferase
reporter gene (p1.2Luc), and transiently transfected into L6, 3T3-
L1, GH4C1, HeLa, NIH3T3 and CV-1 cells. The data are expressed
as relative luciferase activity (arbitrary light units/Wg protein of the
UCP2 promoter/that of the SV40 promoter). Values represent
means þ S.E. of triplicate determinations. At least three independ-
ent experiments were performed. B: L6 cells were transiently trans-
fected with the indicated plasmids, and luciferase activity was meas-
ured. Values are presented as means þ S.E. of triplicate
determinations. The controls used were the promoterless luciferase
plasmid (pGL3 basic) and SV40 promoter (pGL3 control).
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contains a typical TATA box in the promoter region, the
UCP2 gene possesses no typical TATA or CAAT boxes in
the appropriate positions. Sequence analysis of the UCP2
promoter region revealed several potential consensus sequen-
ces for transcriptional factors. Deletion analysis of the pro-
moter region revealed that several putative SP1, CREB and
AP2 binding sites may be important for the basic promoter
activity. Furthermore, it is of interest that there were consen-
sus binding sites for MyoD (a transcriptional regulator in
myoblasts and skeletal muscle), GRE, AP1 and AP2 in the
strong positive regulatory region. Further studies are required
to determine whether these binding sites are functional.
We also examined the promoter activity of the UCP2 gene
in several cell lines. L6 cells were derived from rat skeletal
muscle, while 3T3-L1, CV-1, HeLa, NIH3T3, and GH4C1
cells were derived from rat preadipocytes, embryonic monkey
kidney, human chorionic carcinoma, mouse embryonic ¢bro-
blasts, and rat pituitary tumor, respectively. Signi¢cant pro-
moter activity was observed in all cell lines, and even NIH3T3
cells showing the lowest level of expression exhibited at least
10-fold higher expression (V7000 ALU/10 s/Wg protein) than
that of the promoterless construct (pGL3 basic). Unexpect-
edly, very strong promoter activity was observed in the pitui-
tary-derived GH4C1 cells, and the level of expression was
higher than that of muscle L6 cells. Therefore, UCP2 may
play an important role in the pituitary.
UCP1 gene expression is tightly restricted to the thermo-
genic brown adipose tissue, and the promoter activity was low
in cells derived from other tissues [15^17]. From the results of
the present study, therefore, we speculated that the strong and
housekeeping gene-like activity of the UCP2 gene promoter
may contribute to the ubiquitous expression of the UCP2
gene.
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